A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient

A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient

Abstract Background Recombinant human erythropoietin, such as epoetin alfa and darbepoetin alfa, is an important therapy for anemia due to chronic renal failure. Allergy to recombinant human erythropoietin and the need for desensitization are rare. Case presentation We report here a novel epoetin al...

Full description

Bibliographic Details
Main Authors: Jaime S. Rosa, Van B. Vuong, Orly Haskin, Anne Y. Liu
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Hypersensitivity
Epoetin alfa
Desensitization
Pediatric
Child
Drug allergy
Online Access:http://link.springer.com/article/10.1186/s13223-018-0233-1

Internet

http://link.springer.com/article/10.1186/s13223-018-0233-1

Similar Items